STIOLTO

No, Stiolto Respimat does not include a steroid. Instead, it contains two bronchodilators, including a long-acting beta2-agonist (LABA) called olodaterol.

STIOLTO RESPIMAT (tiotropium bromide and olodaterol) Inhalation Spray has undergone clinical trials and has been shown to effectively improve lung function and enhance breathing for individuals with COPD throughout the day and night. This medication is a long-acting maintenance treatment that does not contain steroids and aids in managing COPD symptoms.

STIOLTO may result in severe side effects such as potentially life-threatening sudden shortness of breath, rapid or irregular heartbeat, elevated blood pressure, chest pain, tremors, headaches, nervousness, high blood sugar levels, or low blood potassium levels that can lead to muscle weakness or abnormal heart rhythm.

If you are taking albuterol and olodaterol together, it is important to be aware that this combination may lead to an increased risk of cardiovascular side effects. These side effects can include elevated heart rate and blood pressure, as well as irregular heart rhythm. If you have any questions or concerns about this potential risk, it is recommended that you speak with your doctor. This is especially important if you have a history of high blood pressure, arrhythmia, or heart disease.

According to the manufacturer, Boehringer Ingelheim, a Phase 3 clinical trial showed that Spiolto Respimat (tiotropium/olodaterol) reduced the rate of moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease (COPD) compared to Spiriva Respimat (tiotropium bromide).

If you are taking Stiolto Respimat, it is important to inform your doctor about all the medications and supplements you are currently using. This is because Stiolto Respimat may interact with other adrenergic drugs, xanthine derivatives, steroids, diuretics, non-potassium sparing diuretics, MAO inhibitors, tricyclic antidepressants, drugs that prolong QTc intervals, beta-blockers, and other anticholinergics.

The side effects most frequently reported by patients with COPD using SPIRIVA HANDIHALER include upper respiratory tract infection, dry mouth, sinus infection, sore throat, non-specific chest pain, urinary tract infection, indigestion, runny nose, constipation, increased heart rate, and blurred vision.

While it is uncommon, there have been reports of individuals experiencing heart-related issues, such as chest pain, while using Spiriva.

STIOLTO may result in severe side effects such as potentially life-threatening sudden shortness of breath, rapid or irregular heartbeat, elevated blood pressure, chest pain, tremors, headaches, nervousness, high blood sugar levels, or low blood potassium levels that can lead to muscle weakness or abnormal heart rhythm.

To ensure proper usage, it is advised to take two inhalations of STIOLTO RESPIMAT once daily at the same time each day. It is important not to exceed two inhalations within a 24-hour period.

The effects of the medicine begin within 5 minutes and continue for a complete 24 hours. However, it is important to note that STIOLTO RESPIMAT should not be used for sudden COPD symptoms. It is always recommended to have a rescue inhaler with you.

Some of the side effects of albuterol include nervousness or shakiness, headache, throat or nasal irritation, and muscle aches. There are also more serious, but less common, side effects such as a rapid heart rate (tachycardia) or feelings of fluttering or a pounding heart (palpitations).

The average retail price for Stiolto Respimat is $598.86 for a 1, 4GM inhaler with a dosage of 2.5-2.5MCG/ACT. However, by using a NowPatient Rx Advantage Card Stiolto Respimat coupon, the price can be reduced to as low as $400.91 for the same inhaler at participating pharmacies.

Spiriva Respimat enhances breathing by relaxing the airways that transport air to and from the lungs, thereby reducing episodes of symptom exacerbation. The key component in Spiriva Respimat is tiotropium bromide monohydrate.

Yes, Stiolto Respimat is covered by 69% of Medicare prescription drug plans.

Stiolto Respimat (olodaterol / tiotropium), Symbicort (budesonide / formoterol), and Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) are medications used for respiratory conditions. Stiolto Respimat and Symbicort belong to the S3 – Beta-2 Agonists category, while Trelegy Ellipta falls under S9 – Glucocorticoids.

Daliresp (roflumilast), Symbicort (budesonide / formoterol), and Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) are all medications with their respective uses. For more information, patients can refer to the advanced reading materials, while healthcare professionals can access prescribing information.

Spiriva (tiotropium), Advair Diskus (fluticasone / salmeterol), and Albuterol are all available in lower-cost generic versions. These medications have ratings and reviews available.

If you have a history of high blood pressure, arrhythmia, or heart disease, it is important to talk to your doctor about any concerns or questions you may have regarding the use of formoterol and olodaterol together. This combination may lead to increased cardiovascular side effects, including elevations in heart rate and blood pressure, as well as irregular heart rhythm.

After taking Stiolto Respimat (tiotropium / olodaterol), you should experience relief within approximately 5 minutes. The effects of the medication last for 24 hours, providing continuous assistance in making breathing easier.

If you are taking albuterol and olodaterol together, it is important to be aware that this combination may lead to an increased risk of cardiovascular side effects. These side effects can include elevated heart rate and blood pressure, as well as irregular heart rhythm. If you have any questions or concerns about this potential risk, it is recommended that you speak with your doctor. This is especially important if you have a history of high blood pressure, arrhythmia, or heart disease.

If you have allergies to tiotropium, ipratropium, atropine or similar drugs, olodaterol, or any ingredient in STIOLTO, do not use this medication.

Advair is a widely prescribed inhaler for the ongoing management of COPD. It contains a combination of fluticasone, a corticosteroid, and salmeterol, a long-acting bronchodilator. To effectively control COPD symptoms, Advair is taken twice daily as part of a regular maintenance routine.

BREZTRI is a single inhaler that contains three medications, making it a convenient maintenance treatment for COPD. These medications include an inhaled corticosteroid (budesonide), an anticholinergic (glycopyrrolate), and a long-acting beta2-adrenergic agonist (formoterol fumarate).

Step 1: Depress the small, gray safety catch button located on the side of the device to release the clear base. Remove the clear base from the device.
Step 2: Take a pen or marker and write the discard date on the cartridge. The discard date should be set to 3 months from the first date of use.

You can save 25% off the average retail price of $620.23 for the most common version of Stiolto Respimat by using a NowPatient Rx Advantage Card. This medication, which contains TIOTROPIUM and OLODATEROL, is used to treat chronic obstructive pulmonary disease (COPD). With the coupon, you can get Stiolto Respimat for as low as $464.81.

STIOLTO® RESPIMAT® (tiotropium bromide and olodaterol) Inhalation Spray is a medication that combines tiotropium, an anticholinergic, and olodaterol, a long-acting beta2-adrenergic agonist (LABA). It is used for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

If you use Spiriva Respimat at two puffs once daily, it will last for 30 days.

Trelegy and Spiriva are two different types of medication with different mechanisms of action, designed to help with breathing difficulties. Trelegy contains fluticasone furoate, umeclidinium, and vilanterol. It is used once a day for the long-term treatment of airflow obstruction in patients with COPD. Spiriva contains tiotropium, an anticholinergic bronchodilator, as its active ingredient. Spiriva is used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Spiriva is not used for the treatment of sudden asthma attacks. The effectiveness of Trelegy or Spiriva will depend on the condition being treated and each individuals response to their medication.